Distinct brain extracellular vesicle microRNA profiles differ in frontotemporal dementia and Alzheimer's disease.

Overview

1. Translational Medicine Laboratory, Biomedical Research and Innovations Centre, University of Salford, Manchester M5 4NT, United Kingdom

Abstract

Dementia is a syndrome caused by various diseases including Alzheimer's disease (AD) and frontotemporal dementia (FTD) with an estimated global prevalence of 60 million individuals. Recently, therapeutic development in the dementia field has accelerated, with the introduction of monoclonal antibody therapeutics such as Lecanemab and Donanemab. However, AD and FTD patients are still either diagnosed too late to benefit from available therapies or are misdiagnosed due to the clinical overlap between dementia subgroups making therapeutic intervention challenging. This highlights a real need to improve early diagnostic tools of neurodegenerative disease (ND) biomarkers. A potential source of such biomarkers come from small extracellular vesicles (sEVs), groups of cell-derived, lipid-bound assemblies with the capability to cross the blood–brain barrier (BBB) and known to carry pathogenic proteins associated with AD and FTD. A known cargo of sEVs is microRNA (miRNA), regulatory molecules that post-transcriptionally silence gene expression including transcripts of autophagic systems, processes which dysfunction in dementia-causing diseases leading to toxic aggregate build-up, causing neurodegeneration. The targeting of functional machineries in macroautophagy (MA) and chaperone-mediated autophagy (CMA) by different miRNA may vary between AD and FTD mutations, leading to potential biomarkers of disease being highlighted. Through isolating sEVs from the frontal cortex of post-mortem brain tissue of AD, FTD-MAPT, FTD-C9orf72, FTD-GRN and no-disease control patients (Manchester Brain Bank), miRNA cargoes were analysed and compared using real-time quantitative PCR (RT-qPCR). Seven autophagy-associated miRNA candidates (MA: miR-124-3p, miR-30a-5p, miR-128-3p; and CMA: miR-224-5p, miR-373-5p, miR-106a-3p and miR-26b-5p) were tested to identify dementia sub-group variations, used alongside small RNA-sequencing to explore broader miRNA variation within sEV populations. Of the miRNA tested miR-224-5p (P = 1.76 × 10−5) and miR-106a-3p (P = 0.033) showed significant group differences, and further significant pairwise comparison differences [miR-224-5p: AD fold change (FC) = 4.29, MAPT FC = 7.62; miR-106a-5p: AD FC = 5.59] when compared with no disease controls and other dementia subgroups, potentially showing initial diagnostic and differentiating potential. Small RNA-sequencing results revealed 8 AD, 2 FTD-GRN, 52 FTD-MAPT and 12 FTD-C9orf72 differentially expressed sEV-miRNAs when compared with no disease controls. Further direct comparisons between AD versus FTD mutation-derived sEV cargoes, and even FTD mutation versus FTD mutation-derived sEV cargoes, identified additional miRNA with differentiating capabilities. These findings demonstrate sEV-derived miRNA signatures vary across dementia sub-types and suggest potential roles of sEV cargoes in both disease diagnostics and identifying drivers of ND, such as autophagic impairments and signalling pathways.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper says that its authors' code is available on request: it was not published with the paper, so there is nothing to verify.

The paper's code and data availability statement is in the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none (its code is available on request), so it has no map.

Data

No dataset and no data link were found in the paper.

Data availability

The data supporting the findings of the current study are available from the corresponding author (G.L.) upon reasonable request. Additionally, code is available from the corresponding author upon reasonable request.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 4 authors, 5 keywords, 1 funder, 60 references.

Cite

This paper

Morgan, J., Aarons, T., Mukhopadhyay, A., & Lace, G. (2026). Distinct brain extracellular vesicle microRNA profiles differ in frontotemporal dementia and Alzheimer's disease. Brain communications, 8(4), fcag277. https://doi.org/10.1093/braincomms/fcag277

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1016/j.omta.2026.201757

Extracellular vesicles as biomarkers of disease progression and therapeutic response in patients with spinal muscular atrophy.

Journal: Molecular therapy. Advances

In common: 3 references

[2] doi:10.3389/fnagi.2026.1788991

Plasma multi-miRNA models classify Alzheimer's, Parkinson's, and Lewy body dementia.

Journal: Frontiers in aging neuroscience

In common: Alzheimer's / dementia, cellular / molecular, 2 references

[3] doi:10.1038/s41467-026-74541-8 [code]

SECmeres outperform extracellular vesicles as potential blood RNA biomarkers for Alzheimer's disease.

Journal: Nature communications

In common: Alzheimer's / dementia, 2 references

[4] doi:10.1016/j.nbd.2026.107475

Human TDP-43 expression worsens FTD-related phenotypes in progranulin-insufficient mice.

Journal: Neurobiology of disease

In common: Alzheimer's / dementia, cellular / molecular, 1 reference

[5] doi:10.3389/fnins.2026.1799542

Disease-associated RNA and protein signatures in iPSC-derived microglia model of Alzheimer's disease.

Journal: Frontiers in neuroscience

In common: Alzheimer's / dementia, cellular / molecular, 1 reference

[6] doi:10.3892/ijmm.2026.5849

miR‑223‑3p promotes microglial lactylation and M1 polarization via the FBXW7/Notch1/Hes1/SIRT1 axis.

Journal: International journal of molecular medicine

In common: Alzheimer's / dementia, cellular / molecular, 1 reference

[7] doi:10.1093/brain/awaf443 [code]

Cellular signatures underlying functional resilience in presymptomatic frontotemporal dementia.

Journal: Brain : a journal of neurology

In common: Alzheimer's / dementia, 1 reference

[8] doi:10.1002/advs.202600020 [code]

Early Retinal UCHL1 Dysregulation Coupled With Synaptic Loss Reflects Alzheimer's Disease Severity.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

In common: Alzheimer's / dementia, cellular / molecular, 1 reference

[9] doi:10.1038/s41467-026-75895-9

Distinct Filament Conformation for Receptor-Bound Amyloid-β from Alzheimer's Disease Brain.

Journal: Nature communications

In common: Alzheimer's / dementia, cellular / molecular, 1 reference

[10] doi:10.1186/s12987-026-00825-2

Acute amyloid-β exposure disrupts insulin signaling in hCMEC/D3 blood-brain barrier endothelial cells.

Journal: Fluids and barriers of the CNS

In common: Alzheimer's / dementia, cellular / molecular, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.